FMP
Cardio Diagnostics Holdings, Inc.
CDIO
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0.29 USD
0.0023 (0.793%)
About
ceo
Dr. Meeshanthini V. Dogan Ph.D.
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
CIK
0001870144
ISIN
US14159C1036
CUSIP
14159C103
Address
400 N Aberdeen St
Phone
855 226 9991
Country
US
Employee
7
IPO Date
Jan 14, 2022
Key Executives
